抗血管生成药物-话题@MedSci

#抗血管生成药物#

8篇内容 | 855人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2192795, encodeId=f16b2192e95a0, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a> <a href='/topic/show?id=3c1ee4340c9' target=_blank style='color:#2F92EE;'>#神经母细胞瘤#</a>, objectTitle=JCO：化疗联合抗血管生成药物治疗难治/复发神经母细胞瘤, objectType=article, longId=814438, objectId=907f81443864, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=907f81443864, replyNumber=0, likeNumber=28, createdTime=2024-03-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=907f81443864, moduleTitle=JCO：化疗联合抗血管生成药物治疗难治/复发神经母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907f81443864)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173311, encodeId=4d7421e3311b2, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=d2ba5e382ac' target=_blank style='color:#2F92EE;'>#放射治疗#</a> <a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a> <a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, objectTitle=读书报告 | 放射治疗联合免疫检查点抑制剂和抗血管生成药物治疗肝细胞癌, objectType=article, longId=803926, objectId=fc65803926fc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867593143_4754896.jpeg, objectUrl=/article/show_article.do?id=fc65803926fc, replyNumber=0, likeNumber=43, createdTime=2023-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fc65803926fc, moduleTitle=读书报告 | 放射治疗联合免疫检查点抑制剂和抗血管生成药物治疗肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc65803926fc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1653943, encodeId=0c67165394331, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=《晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2020版）》正式发布，助力晚期NSCLC临床治疗水平提升, objectType=article, longId=200723, objectId=8637200e2372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8637200e2372, replyNumber=0, likeNumber=48, createdTime=2020-11-19, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8637200e2372, moduleTitle=《晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2020版）》正式发布，助力晚期NSCLC临床治疗水平提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8637200e2372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653942, encodeId=350e1653942a5, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=韩小弟教授：抗血管生成药物给胶质母细胞瘤患者带来生存希望, objectType=article, longId=180146, objectId=af1c18014633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1c18014633, replyNumber=0, likeNumber=56, createdTime=2019-10-19, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1c18014633, moduleTitle=韩小弟教授：抗血管生成药物给胶质母细胞瘤患者带来生存希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af1c18014633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653940, encodeId=082c1653940fc, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=抗血管生成药物临床不良反应处理手册, objectType=article, longId=176108, objectId=b05b1e6108b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b05b1e6108b8, replyNumber=0, likeNumber=33, createdTime=2020-07-01, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b05b1e6108b8, moduleTitle=抗血管生成药物临床不良反应处理手册, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b05b1e6108b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653941, encodeId=b58c165394128, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2019版）, objectType=article, longId=176144, objectId=ed5d1e614425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed5d1e614425, replyNumber=0, likeNumber=40, createdTime=2020-05-31, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed5d1e614425, moduleTitle=晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2019版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed5d1e614425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653939, encodeId=7ed91653939d2, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=晚期非小细胞肺癌抗血管生成药物治疗中国呼吸领域专家共识（2016年版）, objectType=article, longId=83667, objectId=9ab08366e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ab08366e23, replyNumber=0, likeNumber=40, createdTime=2017-02-10, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ab08366e23, moduleTitle=晚期非小细胞肺癌抗血管生成药物治疗中国呼吸领域专家共识（2016年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ab08366e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653937, encodeId=c59e165393eed, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=Int J Cancer：抗血管生成药物多巴胺或可用于癌症治疗, objectType=article, longId=45331, objectId=fc7f4533128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc7f4533128, replyNumber=0, likeNumber=52, createdTime=2015-09-16, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc7f4533128, moduleTitle=Int J Cancer：抗血管生成药物多巴胺或可用于癌症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc7f4533128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653938, encodeId=d99c1653938f8, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=PNAS：抗血管生成药物可显著改善肺结核的治疗, objectType=article, longId=46606, objectId=4ad14660638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ad14660638, replyNumber=0, likeNumber=48, createdTime=2015-05-16, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ad14660638, moduleTitle=PNAS：抗血管生成药物可显著改善肺结核的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ad14660638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653936, encodeId=8f12165393675, content=<a href='/topic/show?id=d04855e76b4' target=_blank style='color:#2F92EE;'>#抗血管生成药物#</a>, objectTitle=Nature：抗血管生成药物治疗癌症的局限性, objectType=article, longId=5000, objectId=2cff5000a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cff5000a3, replyNumber=0, likeNumber=45, createdTime=2013-01-12, rootId=0, userName=marongnuan, userId=392b24414274, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cff5000a3, moduleTitle=Nature：抗血管生成药物治疗癌症的局限性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cff5000a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗血管生成药物

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #抗血管生成药物# #神经母细胞瘤#

JCO：化疗联合抗血管生成药物治疗难治/复发神经母细胞瘤

2024-03-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #放射治疗# #抗血管生成药物# #免疫检查点抑制剂#

读书报告 | 放射治疗联合免疫检查点抑制剂和抗血管生成药物治疗肝细胞癌

2023-12-06发表于上海

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

《晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2020版）》正式发布，助力晚期NSCLC临床治疗水平提升

2020-11-19

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

韩小弟教授：抗血管生成药物给胶质母细胞瘤患者带来生存希望

2019-10-19

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

抗血管生成药物临床不良反应处理手册

2020-07-01

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

晚期非小细胞肺癌抗血管生成药物治疗中国专家共识（2019版）

2020-05-31

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

晚期非小细胞肺癌抗血管生成药物治疗中国呼吸领域专家共识（2016年版）

2017-02-10

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

Int J Cancer：抗血管生成药物多巴胺或可用于癌症治疗

2015-09-16

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

PNAS：抗血管生成药物可显著改善肺结核的治疗

2015-05-16

marongnuan (审核中...)

前往app查看评论内容

#抗血管生成药物#

Nature：抗血管生成药物治疗癌症的局限性

2013-01-12

科室
- - 订阅+
  - 更多科室
工具
服务